TAKRIVEL
LIVE

Serial Number

79269416

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Aug 21, 2019

Add to watchlist:

No watchlists yet
View on USPTO

TAKRIVEL Trademark

Serial Number: 79269416 • Registration: 6055734

TAKRIVEL is a trademark filed by NOVARTIS AG on August 21, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,174 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

August 21, 2019

Registration Date

May 19, 2020

Published for Opposition

March 3, 2020

Cancellation Date

January 13, 2022

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo- skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Aug 9, 2022 DENC
DEATH OF INTERNATIONAL REGISTRATION
Aug 9, 2022 DETH
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 10, 2020 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Sep 21, 2020 FICS
FINAL DISPOSITION PROCESSED
Sep 21, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 19, 2020 FICR
NOTIFICATION PROCESSED BY IB
Jul 10, 2020 GPNX
REGISTERED-PRINCIPAL REGISTER
May 19, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 3, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 3, 2020 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 12, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 12, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 12, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 28, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 28, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 28, 2020 CRFA
ASSIGNED TO LIE
Jan 24, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 16, 2020 TROA
REFUSAL PROCESSED BY IB
Jan 3, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 11, 2019 RFCS
REFUSAL PROCESSED BY MPU
Dec 11, 2019 RFRR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 22, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 22, 2019 REAP
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 16, 2019 RFCR
NON-FINAL ACTION WRITTEN
Nov 15, 2019 CNRT
ASSIGNED TO EXAMINER
Nov 15, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 22, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 16, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 15, 2019 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Oct 10, 2019 SDRC